Comparative Pharmacology
Head-to-head clinical analysis: MINOXIDIL versus THEROXIDIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MINOXIDIL versus THEROXIDIL.
MINOXIDIL vs THEROXIDIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Minoxidil is a potassium channel opener that hyperpolarizes vascular smooth muscle cells, leading to vasodilation. In hair follicles, it promotes hair growth by increasing blood flow and prolonging the anagen phase, possibly through stimulation of prostaglandin synthesis.
Theroxidil is a vasodilator that acts by opening potassium channels in vascular smooth muscle, leading to hyperpolarization and relaxation. It also inhibits platelet aggregation and reduces peripheral vascular resistance.
Oral: 5-40 mg/day in 1-2 divided doses, starting at 5 mg/day and titrating upward; Topical: 1 mL of 2% or 5% solution twice daily.
5 mg orally once daily, increased to 10 mg after 4 weeks as tolerated.
None Documented
None Documented
Clinical Note
moderateMinoxidil + Etacrynic acid
"The risk or severity of adverse effects can be increased when Minoxidil is combined with Etacrynic acid."
Clinical Note
moderateMinoxidil + Furosemide
"The risk or severity of adverse effects can be increased when Minoxidil is combined with Furosemide."
Clinical Note
moderateMinoxidil + Bumetanide
"The risk or severity of adverse effects can be increased when Minoxidil is combined with Bumetanide."
Clinical Note
moderateMinoxidil + Travoprost
Terminal elimination half-life: 4.2 hours; clinical context: may be prolonged in renal impairment (up to 18 hours), requiring dose adjustment.
Terminal elimination half-life 24-30 hours; steady-state reached after 4-5 days; clinically significant for once-daily dosing
Renal: 90% as unchanged drug and metabolites; fecal: 10% via bile.
Approximately 60% renal (15% unchanged, 45% as glucuronide metabolites), 40% fecal/biliary as metabolites
Category A/B
Category C
Vasodilator / Hair Growth Stimulant
Vasodilator
"Minoxidil may increase the hypotensive activities of Travoprost."